Preoperative induction chemotherapy with weekly paclitaxel and carboplatin for clinical-stage IB-IIIA non-small cell lung cancer

被引：0
|
作者：
Tsuboi, M [1 ]
Ohira, T [1 ]
Hayashi, A [1 ]
Kajiwara, N [1 ]
Uchida, O [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Thorac Surg, Tokyo, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80723-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [31] Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer
    Splinter, TAW
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 59 - 61
  • [32] Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)
    Fabi, A
    De Marco, S
    Barduagni, M
    Gamucci, T
    Cortesi, E
    De Marinis, F
    Ferraresi, V
    Saltarelli, R
    Gabriele, A
    Accettura, C
    Cognetti, F
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
  • [33] nab-Paclitaxel in Combination With Weekly Carboplatin With Concurrent Radiotherapy in Stage III Non-Small Cell Lung Cancer
    Lammers, Philip Edward
    Lu, Bo
    Horn, Leora
    Shyr, Yu
    Keedy, Vicki
    ONCOLOGIST, 2015, 20 (05): : 491 - 492
  • [34] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [35] Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for Stage III non-small cell lung cancer
    Choong, Nicholas W.
    Vokes, Everett E.
    Haraf, Daniel J.
    Tothy, Peter K.
    Ferguson, Mark K.
    Kasza, Kristen
    Rudin, Charles M.
    Hoffman, Philip C.
    Krauss, Stuart A.
    Szeto, Livia
    Mauer, Ann M.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 59 - 67
  • [36] Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer
    Su, Chunxia
    Xu, Ying
    Li, Xuefei
    Ren, Shengxiang
    Zhao, Chao
    Hou, Likun
    Ye, Zhiwei
    Zhou, Caicun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5509 - 5518
  • [37] Adjuvant treatment of completely resected stage IB-IIIA non-small-cell lung cancer - a retrospective study with cisplatin or carboplatin and oral vinorelbine
    Engel-Riedel, W.
    Alten, N.
    Bachinger, A.
    Magnet, F. S.
    Ludwig, C.
    Stoelben, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S805 - S805
  • [38] Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer
    Rizvi, N. A.
    Rusch, V.
    Zhao, B.
    Senturk, E.
    Schwartz, L.
    Fury, M.
    Downey, R.
    Rizk, N.
    Krug, L.
    Kris, M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
    Bunn, PA
    Kelly, K
    Mikhaeel, N
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
  • [40] Adjuvant Chemotherapy for Patients with Stage IB Non-Small Cell Lung Cancer
    Wang, Jia
    Yue, Yang
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S641 - S642
12345